Research Applications and Considerations GHK-Cu liver research covers HSC activation inhibition via JNK/AP-1 and Nrf2/MMP-13 pathways, TGF-1 Smad-independent signalling modulation, primary hepatocyte oxidative cytoprotection (HO, APAP, ethanol models), CCl in vivo fibrosis attenuation with Sirius Red and hydroxyproline endpoints, NAFLD/MASLD lipid accumulation via AMPK-CPT1A-FAO, metallothionein copper buffering and ICP-MS hepatic copper quantitation, and alcohol-induced steatohepatitis antioxidant protection
Adjusting protocols for specific goals While the standard protocol serves most users well, specific goals may benefit from adjusted approaches
At the midpoint between the two pKa values, the following measure of net negative and hint of net positive particles balance, so that the typical net charge of all structures present is zero
A., Netea, M
10.1073/pnas.1010529108 Proc Natl Acad Sci U S A
For a 5mg vial reconstituted with 2mL bacteriostatic water: 5mg 2mL = 2.5mg/mL concentration